162 related articles for article (PubMed ID: 37404974)
1. Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline.
Feduccia AA; Jerome L; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R
Focus (Am Psychiatr Publ); 2023 Jul; 21(3):306-314. PubMed ID: 37404974
[TBL] [Abstract][Full Text] [Related]
2. Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline.
Feduccia AA; Jerome L; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R
Front Psychiatry; 2019; 10():650. PubMed ID: 31572236
[TBL] [Abstract][Full Text] [Related]
3. MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.
Mithoefer MC; Feduccia AA; Jerome L; Mithoefer A; Wagner M; Walsh Z; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R
Psychopharmacology (Berl); 2019 Sep; 236(9):2735-2745. PubMed ID: 31065731
[TBL] [Abstract][Full Text] [Related]
4. A Review of MDMA-Assisted Therapy for Posttraumatic Stress Disorder.
Lewis BR; Byrne K
Focus (Am Psychiatr Publ); 2023 Jul; 21(3):247-256. PubMed ID: 37404966
[TBL] [Abstract][Full Text] [Related]
5. 3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review.
Inouye A; Wolfgang A
Cureus; 2022 Jun; 14(6):e26402. PubMed ID: 35915689
[TBL] [Abstract][Full Text] [Related]
6. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial.
Mithoefer MC; Mithoefer AT; Feduccia AA; Jerome L; Wagner M; Wymer J; Holland J; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R
Lancet Psychiatry; 2018 Jun; 5(6):486-497. PubMed ID: 29728331
[TBL] [Abstract][Full Text] [Related]
7. 3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial.
Ot'alora G M; Grigsby J; Poulter B; Van Derveer JW; Giron SG; Jerome L; Feduccia AA; Hamilton S; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R
J Psychopharmacol; 2018 Dec; 32(12):1295-1307. PubMed ID: 30371148
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials.
Jerome L; Feduccia AA; Wang JB; Hamilton S; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R
Psychopharmacology (Berl); 2020 Aug; 237(8):2485-2497. PubMed ID: 32500209
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder: A systematic review and meta-analysis.
Bahji A; Forsyth A; Groll D; Hawken ER
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109735. PubMed ID: 31437480
[TBL] [Abstract][Full Text] [Related]
10. MDMA-Based Psychotherapy in Treatment-Resistant Post-Traumatic Stress Disorder (PTSD): A Brief Narrative Overview of Current Evidence.
Riaz K; Suneel S; Hamza Bin Abdul Malik M; Kashif T; Ullah I; Waris A; Di Nicola M; Mazza M; Sani G; Martinotti G; De Berardis D
Diseases; 2023 Nov; 11(4):. PubMed ID: 37987270
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of MDMA-assisted psychotherapy for treatment of posttraumatic stress disorder: A systematic review and meta-analysis from randomized controlled trials.
Yang J; Wang N; Luo W; Gao J
Psychiatry Res; 2024 Jun; 339():116043. PubMed ID: 38896930
[TBL] [Abstract][Full Text] [Related]
12. MDMA-Assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder: A Systematic Review With Meta-Analysis.
Smith KW; Sicignano DJ; Hernandez AV; White CM
J Clin Pharmacol; 2022 Apr; 62(4):463-471. PubMed ID: 34708874
[TBL] [Abstract][Full Text] [Related]
13. A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD).
Oehen P; Traber R; Widmer V; Schnyder U
J Psychopharmacol; 2013 Jan; 27(1):40-52. PubMed ID: 23118021
[TBL] [Abstract][Full Text] [Related]
14. Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder.
Zeifman RJ; Kettner H; Ross S; Weiss B; Mithoefer MC; Mithoefer AT; Wagner AC
Eur J Psychotraumatol; 2024; 15(1):2297536. PubMed ID: 38174611
[TBL] [Abstract][Full Text] [Related]
15. Progress and promise for the MDMA drug development program.
Feduccia AA; Holland J; Mithoefer MC
Psychopharmacology (Berl); 2018 Feb; 235(2):561-571. PubMed ID: 29152674
[TBL] [Abstract][Full Text] [Related]
16. Effects of Selective Serotonin Reuptake Inhibitor Use on 3,4-Methylenedioxymethamphetamine-Assisted Therapy for Posttraumatic Stress Disorder: A Review of the Evidence, Neurobiological Plausibility, and Clinical Significance.
Price CM; Feduccia AA; DeBonis K
J Clin Psychopharmacol; 2022 Sep-Oct 01; 42(5):464-469. PubMed ID: 36018231
[TBL] [Abstract][Full Text] [Related]
17. The entactogen 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) as a treatment aid in psychotherapy and its safety concerns.
Baldo BA
Arch Toxicol; 2024 May; ():. PubMed ID: 38743292
[TBL] [Abstract][Full Text] [Related]
18. MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled trial.
Ching TH; Williams MT; Wang JB; Jerome L; Yazar-Klosinski B; Emerson A; Doblin R
J Psychopharmacol; 2022 Aug; 36(8):974-986. PubMed ID: 35727042
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
